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PDGFRα plays a crucial role in 
connective tissue remodeling
Shinjiro Horikawa1,2, Yoko Ishii1, Takeru Hamashima1, Seiji Yamamoto1, Hisashi Mori3, 
Toshihiko Fujimori4, Jie Shen1, Ran Inoue3, Hirofumi Nishizono5, Hiroshi Itoh6, 
Masataka Majima7, David Abraham8, Toshio Miyawaki2,† & Masakiyo Sasahara1
Platelet derived growth factor (PDGF) plays a pivotal role in the remodeling of connective tissues. 
Emerging data indicate the distinctive role of PDGF receptor-α (PDGFRα) in this process. In the present 
study, the Pdgfra gene was systemically inactivated in adult mouse (α-KO mouse), and the role of 
PDGFRα was examined in the subcutaneously implanted sponge matrices. PDGFRα expressed in the 
fibroblasts of Pdgfra-preserving control mice (Flox mice), was significantly reduced in the sponges 
in α-KO mice. Neovascularized areas were largely suppressed in the α-KO mice than in the Flox 
mice, whereas the other parameters related to the blood vessels and endothelial cells were similar. 
The deposition of collagen and fibronectin and the expression of collagen 1a1 and 3a1 genes were 
significantly reduced in α-KO mice. There was a significantly decrease in the number and dividing 
fibroblasts in the α-KO mice, and those of macrophages were similar between the two genotypes. 
Hepatocyte growth factor (Hgf) gene expression was suppressed in Pdgfra-inactivated fibroblasts and 
connective tissue. The findings implicate the role of PDGFRα-dependent ECM and HGF production 
in fibroblasts that promotes the remodeling of connective tissue and suggest that PDGFRα may be a 
relevant target to regulate connective tissue remodeling.
Connective tissue remodeling (CTR) is an essential process during the healing of wounds and fibrotic diseases 
as well as in the progression of tumors1. The process of remodeling is affected by numerous factors, including 
age, nutritional deficiencies, metabolic diseases, the type of tumor, and others2–4. Sequences of cellular events 
are involved in CTR, such as the recruitment of inflammatory cells, fibroplasia, new blood vessel formation, and 
deposition of extra-cellular matrix (ECM). Further understanding of the underlying molecular mechanisms of 
CTR is essential for the care of impaired healing processes such as in case of intractable ulcers as well as for the 
development of anti-fibrotic therapies and anti-cancer strategies.
CTR is regulated by a number of growth factors and cytokines5. Among the regulators are members of the 
PDGF family, including PDGF-A, -B, -C and -D. These PDGF-ligands are assembled as disulfide-linked homo- or 
hetero-dimers, and they bind to and activate two types of PDGF receptors, PDGFRα and PDGFRβ 6. The PDGFs 
have been assumed to carry out crucial functions in several stages of the wound healing process7. The role of the 
PDGF-B/PDGFRβ interaction in promoting the recruitment of fibroblasts, pericytes, and endothelial cells to 
enhance wound healing in experimentally induced rodent skin injury has been well-documented8–10. On similar 
lines, recombinant human variants of PDGF-BB (also known as, Becaplermin) are FDA-approved drugs that have 
been successfully applied against intractable ulcers11.
On the other hand, emerging data are indicating the relevance of PDGFRα in CTR12. Enhancement of the 
intrinsic PDGFR signal, evoked by mutational activation of Pdgfra, but not Pdgfrb, systemically induced fibroblastic 
hyperplasia and increased ECM deposition similar to that observed in collagen diseases13. A good correlation has 
been observed between the upregulation of the PDGF-A/PDGFRα axis and enhanced healing of skin wounds 
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observed in mice in which the gene for the nuclear factor I-C has been knocked out14. Additionally, PDGFRα binds 
to PDGF-C with high affinity and has been suggested to mediate angiogenesis and fibroblastic cell proliferation 
in ischemic tissue and tumor stroma2,15–18. Thus, it has been suggested that PDGFRα might contribute to CTR 
through a different mechanism than that of PDGFRβ . However, the functional relevance of PDGFRα in CTR 
remains largely unknown and demands further exploration.
In the present study, in order to understand the role of PDGFRα in CTR, we established a mouse line (α -KO) 
in which the Pdgfra gene was ubiquitously inactivated by tamoxifen-induced Cre recombinase. Then, the effect of 
the knockdown was examined in CTR using the sponge-implant model, which model has been adopted for the 
accurate quantification of angiogenic and fibrogenic responses in vivo19. While PDGFRα expression was prin-
cipally observed in fibroblasts within the ingrowing connective tissues of the sponge matrices implanted in the 
control mice (Flox mice), it was effectively depleted in the fibroblasts of the α -KO mice. Decreased angiogenesis 
and ECM deposition were the most striking phenotypes during CTR of the α -KO mice. These phenotypes were 
different from those obtained after PDGFRβ inhibition8,10 and suggest a distinctive role for PDGFRα during CTR.
Results
Tamoxifen suppresses PDGFRα expression in skin fibroblasts of Pdgfra-inactivated (α-KO) 
mice. Neither male nor female mice, with tamoxifen-induced systemic inactivation of Pdgfra, showed apparent 
adverse effects during experiments. The body weights were similar between the two mouse genotypes within the 
same sex (Supplementary Fig. 1a). In normal skin of the Flox mice, even after tamoxifen treatment, PDGFRα was 
expressed in the spindle-shaped fibroblasts of the dermis and the subcutaneous connective tissue (Supplementary 
Fig. 1b, left). In contrast, PDGFRα expression was largely suppressed in the α -KO mice (Supplementary Fig. 1b, 
right).
Tamoxifen suppresses PDGFRα expression in ingrowing connective tissue of α-KO mice. The 
role of PDGFRα in CTR was examined by the use of sponge implantation model in mice. Because tamoxifen has an 
estrogen-like activity, both sexes of mice were subjected to the initial part of the study. As the ingrowth of connective 
tissue was very small at day 7 (data not shown), tissue responses were analyzed at days 14 and 28 after implantation. 
Sponge implanted in the back skin was excised after 14 days (Supplementary Fig. 2a, upper), and the H&E staining 
of the cut surface indicated abundant ingrowth of the newly synthesized connective tissue, which consisted of a 
mixture of round-shaped inflammatory cells, spindle-shaped cells and blood vessels (Supplementary Fig. 2a, lower).
The efficiency of gene inactivation was examined in the implanted sponge matrices. The level of Pdgfra mRNA 
was largely decreased in the α -KO mice, compared with that in the Flox mice at days 14 and 28 in both sexes, and 
the differences between the two genotypes were significant in real-time PCR analyses (Supplementary Fig. 2b). 
The level of Pdgfrb mRNA was significantly lower in α -KO than in Flox mice at day 14 in both sexes, and at day 
28 in males, but was similar between two genotypes at day 28 in females (Supplementary Fig. 2b). The level of 
PDGFRα protein in sponge was largely suppressed in α -KO mice, compared with that in the Flox mice at days 14 
and 28 in both sexes, and the differences between two genotypes were found to be significant in western blotting 
(Supplementary Fig. 2c). The level of PDGFRβ protein was significantly lower in the α -KO mice than in the Flox 
mice in males, but was similar in both genotypes in females at days 14 and 28 (Supplementary Fig. 2d).
Expression of PDGFRα was suppressed in the fibroblast of α-KO mice. Immunofluorescence 
of the ingrowing connective tissue within sponge matrices from the Flox mice detected PDGFRα within 
spindle-shaped fibroblast-like cells, and it was colocalized with PDGFRβ in these cells (Fig. 1a, upper row). 
PDGFRα immuno-positivities were largely decreased, leaving PDGFRβ staining positive in these spindle-shaped 
cells in the α -KO mice on the 14th day after implantation (Fig. 1a, bottom row). In the double immunofluorescence 
with cell-type specific marker, PDGFRα was not colocalized with CD31, a marker of vascular endothelial cells in 
the Flox mice (Fig. 1b). Notably, PDGFRα was not detected in CD31-positive-mimicking tip cells, a subset of vas-
cular endothelial cells (arrowhead in Fig. 1b)20. Similarly, PDGFRα was not detected in the blood vessel-associated 
alpha smooth muscle actin (α SMA)-positive cells that correspond to the vascular smooth muscle cells and/or 
pericytes (Fig. 1c). PDGFRα did not also colocalize with F4/80, a macrophage-specific marker (Fig. 1d). The 
results suggest that PDGFRα was mainly expressed in spindle-shaped fibroblasts in the Flox mice, as had been 
reported previously8,10, but was effectively suppressed in the newly synthesized connective tissues within sponge 
matrices of the α -KO mice.
Reduced angiogenesis in α-KO mice. Newly synthesized connective tissue that had grown into the 
implanted sponge matrices was histologically compared between the two mouse genotypes. The growth-end of 
CD31-positive blood vessels was traced in CD31 immuno-stained sections, and the vascularized areas within 
the sponge matrices were calculated (Fig. 2a,b). The CD31-positive vascularized areas were highly suppressed 
in the α -KO mice than in the Flox mice in both sexes on the 14th day after implantation (Fig. 2c). While the 
vascularized areas increased from day 14 to 28 in all groups of mice, the areas were significantly smaller in the 
male α -KO mice than in the male Flox mice at day 28. However, in the female mice of both genotypes, the areas 
of vascularization were of similar sizes at day 28 (Fig. 2c). Similar experiment was conducted using collagen type 
IV as a blood vessel-specific ECM, and the identical results were obtained as those obtained in CD31-staining 
(Supplementary Fig. 3).
To understand the underlying mechanism of decreased vascularized area in the male α -KO mice, parameters 
related to blood vessels in sponge matrices were examined in the male mice on the 14th day after implantation 
(Fig. 2d–g). CD31-positive blood vessels of similar sizes were detected in both genotypes (Fig. 2d). While the 
density of CD31-positive blood vessels was significantly lower in the α -KO mice than in the Flox mice (Fig. 2e), 
the difference in blood vessel density was much smaller than that in vascularized area in the comparison of the 
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Figure 1. Immunofluorescence analysis of PDGFRα expression in implanted sponge.  
(a) Immunofluorescence of PDGFRα (green) and PDGFRβ (red) in Flox mice (upper row) and α -KO mice 
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two genotypes (Fig. 2c). The number of Ki67-positive proliferating endothelial cells and the composition ratio 
of the CD31-positive blood vessels of various diameters were similar between the two genotypes (Fig. 2f,g). In 
real-time PCR analyses, among those mRNAs related to endothelial cells, the levels of mRNAs of claudin 5 (Cldn5) 
and cadherin 5 (Cdh5) were significantly suppressed at day 28 in the α -KO mice compared to that in the Flox mice 
(Fig. 2h). Similarly, Cldn5, Cdh5 and Cd31 mRNA expression at day 14, and Cd31 mRNA expression at day 28 were 
tended to be lower in the α -KO mice compared to those in the Flox mice, respectively, while the differences between 
the two genotypes were not significant (Fig. 2h). Thus, the results indicate that decreased vascularized area was 
the most prominent phenotype among the several parameters related to blood vessels after inactivation of Pdgfra.
PDGFRα was not detected within CD31-positive endothelial cells in our double-immunofluorescence 
(Fig. 1b). In addition to this, we further analyzed newly generated PR-MC mice to determine whether PDGFRα 
was expressed in vascular endothelial cells or in their precursor cells (Fig. 3a). In the PR-MC mice, EGFP-positive 
cells represent PDGFRα -expressing cells as EGFP is transcribed under the PDGFRα promoter. In the same mice, 
mCherry-positive cells represent PDGFRα -expressing cells at the time when tamoxifen was administrated, as 
mCherry is a reporter of Cre recombinase that is expressed under the PDGFRα promoter and is activated by 
tamoxifen. EGFP and mCherry were colocalized with each other, but not with CD31, in the sponge matrices 
implanted into PR-MC at day 14 after implantation. Furthermore, most of EGFP or mCherry-positive cells did 
not closely associate with vasculatures delineated by CD31 stainings. These data indicated that PDGFRα was not 
expressed in endothelial cells or their precursors throughout the experiment, and that the pericytes were not major 
population expressing PDGFRα . Together with our previous double-immunofluorescence studies (Fig. 1), the 
results in PR-MC mice led to the suggestion that the vascular phenotype observed in the α -KO mice is likely to be 
a secondary phenomenon after the Pdgfra inactivation that mainly occurred in fibroblasts.
Reduced fibroblast number after PDGFRα suppression in fibroblasts. We examined the number 
and the mitogenic activities of infiltrating macrophages and fibroblasts into the implanted sponge matrices. To 
this end, the immunostaining of periostin and MAC-2, markers for fibroblasts and macrophages respectively, 
was conducted in combination with Ki67 as a marker of cell proliferation. In highly magnified view of multicolor 
immunofluorescence images, many periostin-positive fibroblasts were seen infiltrating into the sponge in the 
Flox mice, while they were relatively few in the α -KO mice (Fig. 3b). In contrast, MAC-2 positive macrophages 
were seen to infiltrate to similar extents in two genotypes (Fig. 3b). In morphometrical analysis, periostin-positive 
fibroblasts were slightly, but significantly, fewer in the α -KO than in the Flox mice (Fig. 3c). The number of peri-
ostin/Ki67-positive proliferating fibroblasts tended to be lower in the α -KO mice than in the Flox mice, while the 
differences between the two genotypes were not significant (Fig. 3d). For dissect out more detail, M phase specific 
marker, phospho-histone H3 (pHH3), staining was performed. Immunofluorescence and morphometrical analysis 
unveiled that percentage of periostin/pHH3-positive dividing fibroblasts were significantly fewer in α -KO than 
in Flox mice (Supplementary Fig. 4a,b). In contrast to fibroblasts, the number of MAC-2-positive macrophages 
and MAC-2/Ki67-positive proliferating macrophages were not significantly different between the two genotypes 
(Fig. 3e,f). Percentage of MAC-2/pHH3-positive dividing macrophages were also similar level in the two genotypes 
(Supplementary Fig. 4c). Similarly to this, M1, M2 and pan-macrophage marker genes were expressed at similar 
levels between the two genotypes (Supplementary Fig. 5a–f). The results show that Pdgfra inactivation suppressed 
the proliferation and infiltration of fibroblasts, but did not significantly affect those of macrophages.
Suppression of PDGFRα decreases ECM accumulation in implanted sponges. Since fibroblasts, 
the main target of Pdgfra inactivation, are the principal source of ECM in connective tissue, the deposition of ECM 
in the ingrowing connective tissue was examined21. In non-polarized and polarized light microscopic views after 
Sirius Red staining, the amount of collagen was apparently lesser in the α -KO mice than in the Flox mice at day 
14 (Fig. 4a). Within the captured polarized light microscopy images, the polarized light, indicative of collagen, was 
estimated to be significantly lower in the α -KO mice compared to that in the Flox mice at day 14 after implantation 
(Fig. 4b). In agreement with these observations, the transcript levels of Col1a1, and Col3a1, both major compo-
nents of ECM in during CTR22,23, were apparently downregulated in the α -KO compared to those in the Flox 
mice at day 14 (Fig. 4c,d). Moreover, cultured fibroblasts isolated from α -KO mice were expressed significantly 
lower transcript levels of Col1a1 and Col3a1 than fibroblasts isolated from Flox mice (Supplementary Fig. 6a,b). 
Discoidin domain-containing receptor 2 (DDR2) has been shown to regulate cell-collagen interactions24, and 
endothelial cell-expressed DDR2, mediates angiogenesis25,26. In both the genotypes, DDR2 was similarly detected 
in CD31-positive vascular endothelial cells as well as in other CD31-negative cell types (Fig. 4e).
Fibronectin is another ECM component that mediates cell adhesion and migration, and critically contributes 
to CTR27,28. The immunoreactivities of fibronectin in regrowing connective tissue are evidently decreased in the 
α -KO than in the Flox mice at day 14 (Fig. 5a). The fibronectin-positive area was significantly reduced in the α -KO 
than in the Flox mice in the immuno-stained sections at day 14 (Fig. 5b). Fn1 mRNA expression was similar in 
both genotypes (data not shown). In agreement with Fn1 mRNA expression in sponge, Fn1 mRNA in fibroblasts 
were similar level in both genotypes (Supplementary Fig. 6c). Integrin α 5, which is one of the major fibronectin 
(bottom row) with nuclear staining (Hoechst, blue). (b–d) Multicolor immunofluorescence analysis of 
PDGFRα expression in Flox mice. Co-staining of PDGFRα (green) and CD31 (red; b), PDGFRα (green) 
and α SMA (red; c), PDGFRα (green) and F4/80 (red, d). The nuclei were stained with Hoechst (blue, b–d). 
PDGFRα was not expressed in endothelial cells, including specific tip cells, vascular smooth muscle cells/
pericytes, and macrophages, all of which are major components of ingrowing connective tissue together with 
fibroblasts. Scale bars indicate 10 μ m, respectively.
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Figure 2. Angiogenesis is suppressed in implanted sponges in α-KO mice. (a–c) Immunohistochemical 
analysis of blood vessel formation in implanted sponge. (a) H&E-stained cross-sectional area of implanted 
sponges at day 14 after implantation (upper row) and immunohistochemistry of CD31 (brown) in the adjacent 
sections (bottom row). Boxed areas in (a) show as high magnification panels in (b) with the vascularized areas 
delineated by dotted lines. Using Flox mice as the control (a, left), CD31 positive vascularized areas in α -KO 
(a, right) were examined in male (c, left) and female (c, right) on days 14 and 28 after implantation. n = 4–5 
mice per group. (d) Double immunostaining of CD31 (brown) and Ki67 (black) and counterstaining with 
hematoxylin (pale blue) in ingrowing connective tissue. The density of CD31-positive blood vessels is higher 
in the Flox (left) as compared with that in the α -KO (right) mice. (e–g) Morphometric analysis of angiogenesis 
and endothelial cell proliferation in connective tissues. Number of blood vessels in vascularized areas (e), Ki67 
positivity in CD31-positive endothelial cells (f), and cumulative percentages of blood vessel diameters (g) of 
both genotypes; n = 4 per group. (h) Real-time PCR analyses of mRNA expression levels of endothelial cell-
related gene Cldn5, Cdh5, and Cd31 in sponges of Flox and α -KO mice. Male mice were analyzed in (d–h). 
*p < 0.05 versus Flox mice; **p < 0.01 versus Flox mice; ***p < 0.001 versus Flox mice. Scale bars indicate 1 mm 
(a), 500 μ m (b), and 100 μ m (d).
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Figure 3. PDGFRα was not detected in blood vessels, and fibroblast recruitment is suppressed in 
implanted sponge in the α-KO mice. (a) Dual reporter assay in PR-MC mice show current activity of the 
PDGFRα promoter and history of tamoxifen-induced Cre activation, as EGFP (green) and mCherry (red), 
respectively. CD31 positive endothelial cells (cyan) are not positive for neither of these two reporter fluorescence 
proteins. Scale bar indicates 50 μ m. (b) Multi-color fluorescence shows that the recruitment of periostin-positive 
fibroblasts (yellow) into the ingrowing connective tissues is suppressed in the α -KO mice. Macrophages (green) 
and Ki67-positive proliferating cells (red) are of the same level in both genotypes. Nuclei are depicted by Hoechst 
staining (blue). Scale bar indicates 20 μ m. (c,d) Morphometrical analysis of fibroblasts. Number of periostin-
positive fibroblasts is significantly less in α -KO mice than in Flox mice (c), but the number of periostin/Ki67-
positive proliferating fibroblasts is similar between the two genotypes (d). (e,f) Morphometrical analysis of 
macrophages. Number of MAC-2 positive macrophages and MAC-2/Ki67-positive proliferating macrophages 
(e,f, respectively) are similar between the two genotypes.
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Figure 4. Collagen deposition is impaired in implanted sponge in α-KO. (a) The collagen deposition was 
examined in the ingrowing connective tissue by Sirius Red staining. Sirius Red staining from Flox (left) and 
α -KO (right) mice. Collagen is stained red under non-polarized microscope (upper row). Thick collagen fibers 
show strong birefringence of yellow to red color, and thin collagen shows a weak and greenish birefringence 
under polarized light microscope (bottom row). (b) Collagenized area of ingrowing connective tissue of male 
mice from both genotypes at day 14 was measured by quantifying polarized area of Sirius Red (mm2); n = 4–5 
mice per group. (c,d) Real-time PCR analyses of representative ECM-related mRNAs in ingrowing connective 
tissue at day14 after implantation. In α -KO mice, Col1a1, and Col3a1 expression levels were significantly 
reduced compared to that in Flox mice sponges; n = 4 per group. *p < 0.05 versus Flox mice; **p < 0.01 versus 
Flox mice. (e) In the sponges implanted in Flox mice, collagen receptor DDR2 (red) expresses in CD31 positive 
blood vessels (green) (upper row). Similarly, DDR2 expresses in CD31 positive blood vessels of the implanted 
sponges in the α -KO mice (bottom row). Nuclei are depicted by Hoechst (blue), and sponges are delineated by 
autofluorescence (cyan). Scale bars indicate 300 μ m (a), and 50 μ m (e).
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receptors, was abundantly detected in CD31-positive vascular endothelial cells as well as in CD31-negative cells 
in both genotypes (Fig. 5c).
Both mRNA and protein expressions of collagen were decreased (Fig. 4, Supplementary Fig. 6), and the protein 
but not mRNA expression of fibronectin was decreased (Fig. 5, Supplementary Fig. 6). Assuming that the reduction 
in deposition of ECM by fibroblasts, in which, decreased collagen synthesis rather than fibronectin was hypoth-
esized as the primary change, after gene-inactivation resulted in decreased vascularization, type I collagen was 
focally injected into the implanted sponge in the α -KO mice for rescue of the vascular phenotypes. However, the 
injection of type I collagen did not affect the CD31-positive vascularized areas in either genotype (data not shown).
Suppression of PDGFRα decreases hepatocyte growth factor (HGF) expression level in implanted 
sponges. Due to the decreased vascularized areas in the α -KO mice, we examined the synthesis of represent-
ative angiogenic growth factors in cultured Flox and α -KO fibroblasts. Hgf mRNA expression was significantly 
lower in α -KO fibroblasts than in Flox cells (Fig. 6a). The abundance of Fgf2 and Cxcl12 transcripts was signifi-
cantly higher in the α -KO fibroblasts compared to the Flox fibroblasts, while Vegfa, Vegfc, and Vash2 levels were 
Figure 5. Fibronectin deposition is impaired in implanted sponge in α-KO mice. (a) Immunohistochemical 
analysis of the fibronectin deposition (brown) in connective tissue-formed sponges. Representative images 
of male Flox (left) and α -KO (right) mice at day 14 after implantation. α -KO mice show lesser extent of 
immunoreactivity to fibronectin compared to Flox mice. (b) In α -KO mice, the fibronectin-depositing area 
is significantly less than in Flox mice. ***p < 0.001 versus Flox mice. n = 4 mice per group. (c) In Flox mice, 
integrin α 5 (red), a component of fibronectin receptor dimer, is expressed in CD31-positive blood vessels 
(green) within the sponge (upper row). Similarly, integrin α 5 is expressed in CD31-positive blood vessels 
of ingrowing connective tissue in the α -KO mice (bottom row). Nuclei are depicted by Hoechst (blue), and 
sponges are visible due to the autofluorescence (cyan). Scale bars indicate 100 μ m (a), and 50 μ m (c).
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similar between the two genotypes (Fig. 6a). In the implanted sponge matrices, Hgf mRNA, but none of the other 
mRNAs examined, was significantly lower in the α -KO than in the Flox mice at day 14 (Fig. 6b). In support of these, 
VEGF-A was detected at similar extent in MAC-2-positive macrophage in both genotypes (Supplementary Fig. 5g).
Based on above data, HGF was focally injected into the implanted sponge for 14 days to rescue the decreased 
vascularization in the α -KO mice. Measurements of the vascularized areas in CD31-stained sections after HGF 
injection showed that they were largely suppressed in both genotypes (Fig. 6d). Moreover, higher magnification 
views of tissue from both genotypes showed that blood vessels tended to be dilated and were accompanied by 
increased Ki67-positive cells (Fig. 6c, Supplementary Fig. 7). Additionally, immunohistochemistry of collagen 
type I and fibronectin proteins showed that improvement of the ECM deposition was observed by HGF admin-
istration in α -KO mice (Supplementary Fig. 8). Thus, it seems that HGF did not enhance the revascularization 
rather induced the maturation of blood vessels; however, it could improve ECM deposition in connective tissues.
Discussion
PDGFs are crucially involved in the tissue remodeling in wound healing, as well as in tumor progression. The 
present study, to the best of our knowledge, is the first characterization of the specific functional contributions 
of PDGFRα in CTR. The formation of new connective tissue was significantly delayed in sponges implanted 
subcutaneously when Pdgfra was inactivated by the Cre-loxP method. The decrease in both ECM-deposition 
and angiogenesis, when PDGFRα expression had been largely suppressed in the α -KO fibroblasts, were the most 
striking phenotypes obtained in the connective tissue growing into the sponge matrices.
PDGFRα was co-expressed along with PDGFRβ within the fibroblasts of the Flox mice, but was substantially 
suppressed in the α -KO mice. The expression of PDGFRα and PDGFRβ can be induced in vascular endothelial cells, 
and has been reported to directly contribute to the blood vessel formation29,30. However, the present study did not 
detect any significant expression of PDGFRα in endothelial cells and macrophages. Double-immunofluorescence 
studies, conducted using markers of these cells, as well as reporter assays in Pdgfra-preserving PR-MC mice could 
not detect the expression of PDGFRα in vascular endothelial cells. Accordingly, the vascular phenotypes observed 
in the connective tissue of the α -KO mice are likely to be due to the disturbed function of fibroblasts induced by 
inactivation of Pdgfra.
Fibroblasts are the principal source of ECM in connective tissue21,31,32, and hence were the primary target of 
Pdgfra inactivation in the present study. Collagens and fibronectin are essential components of the ECM during 
CTR. As the results show, accumulation of collagen and fibronectin was largely suppressed in the ingrowing 
Figure 6. HGF expression is significantly suppressed in implanted sponges in the α-KO mice. (a,b) Real-
time PCR analyses of representative angiogenic factor mRNAs, Hgf, Fgf2, Vegfa, Vegfc, Cxcl12, and Vash2. 
Analyses of cultured fibroblasts (a) and ingrowing connective tissue at day 14 (b) show decreased Hgf; n = 4− 6 
per group. (c,d) The rescue experiments by HGF injection were performed using Flox and α -KO mice.  
(c) Double-immunostaining of CD31 (brown) and Ki67 (black), and counterstaining with hematoxylin (pale 
blue) of ingrowing connective tissue at day 14 after implantation. Representative microscopic views of non-
HGF-treated (vehicle-treated) Flox mice as a control (left), HGF-administrated Flox mice (middle), and HGF-
administrated α -KO mice (right). Dilated blood vessels are found in the HGF-administrated groups compared 
to those in non-HGF-treated mice. Scale bar indicates 50 μ m. (d) HGF administration stabilized blood vessel 
formation in sponges of both genotypes. ***p < 0.001 α -KO versus Flox mice; ###p < 0.001 non-treated Flox 
versus HGF treated Flox mice.
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connective tissue in the α -KO mice, suggesting that the PDGFRα importantly mediates ECM deposition during 
CTR. In the α -KO mice, fibroblast cell number in sponges was decreased, and collagen synthesis in fibroblasts was 
suppressed; both of these findings were supposed to additively contribute to the decreased collagen deposition 
as a direct sequence of Pdgfra inactivation. On the other hand, whereas the deposition of fibronectin was largely 
suppressed in α -KO mice, Fn1 expression was similar between two genotypes both in vivo and in vitro analyses. 
These data suggest that majority of the fibronectin in sponges is derived from plasma as previously reported33. 
Furthermore, the decreased collagen deposition may be the underlying reason of less fibronectin deposition which 
binds to collagen via the collagen-binding domain34 in α -KO mice.
Collagens and fibronectin promote angiogenesis by preparing the matrix framework for new vessel forma-
tion35,36 and by supporting endothelial cell proliferation, survival, and migration37. In the α -KO mice, accumulation 
of collagen and fibronectin was largely suppressed, in accordance with the substantial decrease of angiogenesis. On 
the other hand, the endothelial cells preserved DDR2 and integrin α 5, the receptors for these ECM components 
in the α -KO mice26,38,39. Thus, altered intrinsic nature of endothelial cells were not indicated to be the primary 
cause of decreased neovascularization. Stimulation of angiogenesis has been shown to enhance the rate of healing, 
particularly in impaired healing models such as diabetic subjects40,41, as well as to promote tumor progression18. 
Accordingly, the present observations on ECM deposition and neovascularization indicate that the PDGFRα could 
be an important target to regulate tissue remodeling in diverse diseases.
HGF is a mitogen of endothelial cells and connective tissue cells42. Mesenchymal cells promote angiogenesis 
by secreting angiogenic growth factors and cytokines, among which PDGFRα mediates the expression of fibro-
blast growth factor 2 (FGF2)-induced HGF and vascular endothelial growth factor A (VEGF-A) in these cells43. 
Along this line, real-time PCR analyses indicated that Hgf, but not the other angiogenic factors examined, was 
significantly decreased in both Pdgfra-inactivated fibroblasts and in ingrowing connective tissue of α -KO mice, 
compared to those in Pdgfra-preserving controls. Based on these observations, HGF was focally applied to the 
implanted sponge to improve ingrowth of connective tissue. Applied HGF enhanced the fibroblastic cell prolifer-
ation and the deposition of collagen type I and fibronectin in the ingrowing connective tissue. Furthermore, HGF 
induced the vascular endothelial cell proliferation and vascular dilatation that is one of the important modes of 
actions of HGF to induce angiogenesis44. Accordingly, it was shown that HGF induced by PDGFRα was involved 
in the ECM and vascular remodeling. However, HGF-treatment did not induce ingrowth of blood vessels in Flox 
or α -KO mice. Since HGF and other growth factors associate with ECM through growth factor-binding sites45, it 
is possible that a gradient of growth factor concentration is necessary for inducing neovascularization and such a 
gradient could not be established in absence of the ECM.
In conclusion, we have shown, by using a sponge-implantation mouse model, that PDGFRα mediates CTR. 
Angiogenesis and fibroplasia are interdependent and crucial components of CTR. The reduction in both ECM 
formation and HGF production by Pdgfra-inactivated fibroblasts is likely to be the main reason for the substan-
tial delay in angiogenesis and fibroplasia in the α -KO mice; however, further studies will be required to under-
stand the detailed mechanism of PDGFRα action, and its interaction with other molecular determinants of CTR. 
Furthermore, the results suggest that PDGFRα is an important target to regulate tissue remodeling in diverse 
diseases.
Methods
Generation of conditional gene-inactivation and transgenic mice. Mutant mice, harboring the 
Pdgfra gene in which the exons 4 and 5 were flanked by two loxP sequences (Pdgfraflox/flox), were generated as fol-
lows: Briefly, BAC genomic clone (RP24-148N4), originating from the DNA of C57BL/6 mice and containing the 
Pdgfra gene, was obtained from the BACPAC Resource Center CHORI (Oakland, CA, USA). The targeting vector 
included a DNA fragment containing a loxP sequence and a pgk-neo cassette flanked by two Flp recognition target 
(frt) sites46 inserted into pMC1DTABGHA that derived from pMC1DTApAM47 after replacing the pgk-pA signal 
sequence with the bovine growth hormone-derived pA signal. The embryonic stem cell line RENKA, derived from 
the C57BL/6N strain48, was used and the targeting vector was electroporated as described previously49. The resultant 
male chimeric mice were crossed with female CAG-FLPe deletion mutant mice50 to remove the pgk-neo selection 
cassette and obtain the heterozygous Pdgfraflox/+ strain. Genotyping was performed by PCR using the following 
primers: 5′ -ATGCCAAACTCTGCCTGATTGA-3′ and 5′ -CTCACGGAACCCCCACAAC-3′ . The Flox mice were 
crossbred with chicken β-actin-promoter/CMV-enhancer-driven Cre-transgenic mice harboring tamoxifen-induc-
ible Cre recombinase (Cre-ER+/−; CAGGCre-ER+/−; Jackson Laboratories, Bar Harbor, ME, USA)51. The resultant 
offspring harboring the Pdgfraflox/flox;Cre-ER+/−, and those harboring Pdgfraflox/flox were respectively used as systemic 
Pdgfra-KO (α -KO) mice and as Pdgfra-preserving controls (Flox mice) after tamoxifen administration, as described 
below. Transgenic mice harboring the transgene, which includes the Pdgfra promoter region in combination with 
cre recombinase gene in tandem with enhanced green fluorescent protein (Egfp) gene inserted by internal ribosome 
entry site (IRES) sequence, were generated as follows. Briefly, BAC genomic clone (RP24-148N4), originating from 
the DNA of C57BL/6 mice and containing the Pdgfra gene, was obtained from the BACPAC Resources Center 
CHORI (Oakland, CA). The targeting vector included a DNA fragment of an improved tamoxifen-inducible Cre 
recombinase (CreERT2) and Egfp, both of which were connected by the IRES sequence, and pBigTDEST52, which 
carries a triple repeat of SV40 polyadenylation signal sequence. The embryonic stem cell line TT252, derived from 
the F1 embryo produced by a cross between a C57BL/6 female and a CBA male, was used and the targeting vec-
tor was electroporated as described previously49. The obtained male chimeric mice were crossed with C57BL/6 
mice to obtain the heterozygous Pdgfra-CreERT2-Egfp (PR) strain. Genotyping was performed by PCR using the 
following primers: 5′ -GGCAAGCTGACCCTGAAGTTCATCTGCACC-3′ and 5′ -ATCGCGCTTCTCGTTGG
GGTCTTTGCTCAG-3′ . The PR mice were crossbred with R26RH2B-mCherry/+ mice53 and the resulting offsprings, 
which harbored Pdgfra-CreERT2-Egfp+/−;R26RH2B-mCherry/+ (PR-MC mice), were treated with tamoxifen and used 
as a reporter of Pdgfra gene inactivation within PDGFRα -expressing cells. All the mice were housed at 25 °C with 
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a 12 h light/12 h dark cycle and free access to pellet chow and water. All experimental animal procedures were 
approved by the Committee for Institutional Animal Care and Use at the University of Toyama (Toyama, Japan), 
and experiments were carried out in accordance with the approved guidelines.
Sponge implantation and suppression of PDGFRα expression. Circular sponge discs were implanted 
into 4–5-month-old mutant mice under deep anesthesia as described previously54. Briefly, circular sponge discs 
(5 mm thick, 1.3 cm in diameter) were formed from a sheet of polyurethane form (Komeri, Niigata, Japan) using 
appropriate-sized punch. The discs were soaked in 70% ethanol for 3 hours and the rinsed in sterile distilled water. 
After drying at reduced pressure, all discs were autoclaved before implantation. Tamoxifen (Sigma-Aldrich, St. 
Louis, MO) was orally administered once a day (225 mg/kg body weight) for 5 consecutive days55, starting on days 
0 and 14 after sponge implantation. At days 14 and 28 after implantation, connective tissue-formed sponges were 
excised together with the enclosed sponge implants under deep anesthesia. The obtained tissues were used for 
real-time PCR, western blotting, and histological studies.
Real-time PCR. Total RNA isolation and quantitative real-time PCR analysis were performed as described 
previously56,57. Briefly, for real-time PCR, performed with a Thermal Cycler Dice Real Time System TP800 (Takara, 
Kyoto, Japan), cDNAs were diluted 1:25 in the reaction mixture consisting of SYBR Premix EX Taq II (Takara). 
The real-time PCR program consisted of hot start enzyme activation at 95 °C for 10 s, 40 cycles of amplification at 
95 °C for 10 s and 60 °C for 40 s. Finally, to obtain the dissociation curve, a final cycle was performed at 95 °C for 
1 min, 60 °C for 30 s, and then 95 °C for 10 s. For data analysis, mouse β -actin (Actb) or glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh) housekeeping genes was used as internal control. Induction values were calculated using 
analysis software. Primer sequences are available upon request from the Takara Bio Inc. website (http://www.
takara-bio.co.jp/).
Immunohistochemistry and immunofluorescence staining of paraffin-embedded or frozen 
sections. For paraffin section preparation, the extracted sponges and surrounding connective tissues were 
immediately fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), dehydrated with a graded 
series of ethanol solutions, and embedded in paraffin. The sections (5 μ m in thickness) were subjected to either 
hematoxylin and eosin (H&E) staining or immunostaining. For frozen section preparation, the extracted sponge 
and surrounding connective tissue were immediately fixed with 1% paraformaldehyde in 0.1 M phosphate buffer 
(pH 7.4) at 4 °C overnight, and then transferred to phosphate-buffered saline (PBS). Tissues were submerged in 30% 
PBS-buffered sucrose, and then the entire tissue was embedded in optimal cutting temperature (OCT) compound 
(Sakura Finetek Japan, Tokyo, Japan) and frozen at − 20 °C until solidified. The frozen sections, each 30 μ m in 
thickness, were cut on a CM3000 cryostat (Leica Microsystems, Wetzlar, Germany). Immunohistochemistry and 
immunofluorescence staining was performed as described previously56,58. Briefly, the sections were incubated at 4 °C 
overnight with the following primary antibodies: goat polyclonal anti-PDGFRα (1:100; Neuromics, Edina, MN), 
rabbit monoclonal anti-PDGFRβ (1:100; Epitomics, Burlingame, CA), rat monoclonal anti-F4/80 (1:500; Bio-Rad 
Laboratories, Hercules, CA), rat monoclonal anti-CD31 (1:500; Dianova, Hamburg, Germany), rabbit polyclonal 
anti-Periostin (1:100; Abcam, Cambridge, MA), biotinylated rat monoclonal anti-MAC-2 (1:10; BioLegend, San 
Diego, CA), rat monoclonal anti-Ki67 (1:100; eBioscience, San Diego, CA), rabbit polyclonal anti-GFP (1:100; 
Frontier Institute, Hokkaido, Japan), rabbit polyclonal anti-VEGF-A (1:50; Merck Millipore, Billerica, MA), rabbit 
polyclonal anti-collagen type I (1:250; Abcam), mouse monoclonal anti-fibronectin (1:100; Abcam), rabbit poly-
clonal anti-collagen type IV (1:500; Merck Millipore), and rabbit monoclonal anti-phospho-histone H3 conjugated 
with Alexa-Fluor 488 (1:25; Cell Signaling, Danvers, MA). Colorimetric immunostaining was done using the appro-
priate Histofine Simple Stain Mice System (NICHIREI BIOSCIENCES, Tokyo, Japan) and 3,3′-diaminobenzidine 
tetrahydrochloride (DAB, Dako, Glostrup, Denmark) reaction. The nuclei were counterstained with hematoxy-
lin. For immunofluorescence, the Alexa-Fluor488-, Alexa-Fluor568-, or Alexa-Fluor633-conjugated secondary 
antibodies (Life Technologies Corporation, Carlsbad, CA) were used at 1:500 dilutions. Streptavidin conjugated 
with Alexa-Fluor488 or Alexa-Fluor568 was used for the biotinylated primary antibody. Nuclei were stained with 
Hoechst 33258 (Nacalai Tesque, Koto, Japan). Images were captured by a microscopy system (BX 51; Olympus, 
Tokyo, Japan) connected to a digital camera (DP70; Olympus) or BIOREVO BZ-9000 microscope (Keyence, Osaka, 
Japan), and were processed using Photoshop software (version 7.0; Adobe, San Jose, CA). Immunofluorescence 
staining was imaged by a confocal microscope (TCS-SP5; Leica Microsystems). Montages were created using 
Photoshop software.
Image analysis and quantification. The area occupied by blood vessels in sagittal cross-sections of excised 
sponges was analyzed in CD31- or collagen type IV-stained sections. We defined the area encircled by the tip of 
CD31- or collagen type IV-positive cells and the border of sponge matrices as the vascularized area. The percent-
ages of vascularized area were calculated by following equation; {(area of sponge matrix border)− (area of vascular 
tip line)}/(area of sponge matrix border)× 100 = (vascularized area). The numbers of CD31-positive vascular 
endothelial cells were determined within five randomly selected representative views in vascularized area at high 
power field (× 600 magnification) in a section. To determine the collagen fiber content within the halves of the 
sponge, the tissues were stained with Sirius Red. In Sirius Red-stained sections observed under polarization, thick 
collagen fibers were strongly birefringent and yellow to red, whereas thin collagen fibers were weakly birefringent 
and greenish59. Polarized images were obtained by a microscopy system (BX 51; Olympus) connected to a digital 
camera (DP70; Olympus). The birefringent areas within cross-sections of sponges were quantified by VH Analyzer 
software (VH-H1A5; Keyence). Morphological and morphometric analyses were performed using a BIOREVO 
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BZ-9000 microscope (Keyence) and BZ-II Analyzer software (Keyence). For the fibronectin analysis, fibronectin 
positive areas were normalized by quantified cell areas and analyzed with the BZ-II Analyzer software (Keyence).
Western blot analyses. Tissue preparation and blotting were performed as described previously56–58. 
Membranes were incubated with the following primary antibodies: rabbit polyclonal anti-PDGFRα (1:1000; Santa 
Cruz Biotechnology, Santa Cruz, CA); rabbit polyclonal anti-PDGFRβ (1:500; Merck Millipore), and mouse mon-
oclonal anti-GAPDH (1:5000; Merck Millipore) at 4 °C overnight. The immunoreactive bands of target proteins 
were quantified by VH Analyzer software (VH-H1A5, Keyence, Osaka, Japan), and normalized to the GAPDH 
protein band.
Cell culture. Skins were harvested from postnatal day 1 (P1)-P3 pups of Pdgfraflox/flox;Cre-ER+/− and Pdgfraflox/flox  
mice under the deep anesthesia, incubated with Dulbecco’s modified eagle media (D-MEM, Nacalai Tesque) 
containing 0.3% collagenase (Sigma-Aldrich) in 4 °C for 48 h. The dermis was separated from the epidermis in 
D-MEM containing 10% fetal bovine serum (FBS), and minced by scissors and triturated by pipetting. The cell 
suspension filtered through 100-μ m nylon mesh (BD Bioscience, San Jose, CA) was centrifuged; the pellet was 
then resuspended in DMEM containing 10% FBS and seeded in 10 cm plastic dishes. After several passages, cells 
were stored in − 80 °C until usage for experiments. Both of fibroblasts were seeded on 6-well plate, and were cul-
tured with D-MEM containing 10% FBS for 24 h. After the cells were subjected with 1 μ M of 4-hydroxytamoxifen 
(4-OHT, Sigma-Aldrich) for deleting of Floxed allele for 48 h, resulting α -KO and Flox were generated.
Collagen type I injection. To clarify the role of PDGFRα -induced expression of collagen type I, high density 
collagen type I, extracted from rat tail (30 μ g dissolved in 100 μ l PBS with 0.023 M acetic acid and 0.023 M sodium 
hydroxide; BD Bioscience), was focally injected into sponge implants once a day on days 3 and 7 after implantation. 
The implanted sponges were removed on day 14, and evaluated histologically.
Hepatocyte Growth Factor (HGF) injection. To clarify the role of PDGFRα -induced HGF expression, 
the activated form of human HGF (kindly provided by Professor Kitamura, Tokyo Institute of Technology, School 
and Graduate School of Bioscience and Biotechnology) was topically injected at concentration of 1 μ g in 50 μ L 
PBS, with 0.1% BSA, into sponge implants once a day from days 2 to 13 after implantation. The implanted sponges 
were removed on day 14, and histologically evaluated.
Statistics. Statistical significance was determined using Student’s t-test, or one- or two-way analysis of var-
iance (ANOVA) with Tukey’s multiple comparisons as a post-hoc analysis for ANOVA. P values less than 0.05 
were considered statistically significant. Graphs were drawn using GraphPad Prism 6 (GraphPad Software, Inc., 
La Jolla, CA). Quantified data are presented as mean ± SEM.
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